Genes Help Gum-Disease Germ Harm Arteries

Florida researchers say they've discovered four genes that enable a type of gum disease bacterium called Porphyromonas gingivalis to invade and infect artery cells. The finding offers one possible explanation for a possible link between gum disease and heart disease.

Full article from Health Day

BioBOOM Op/Ed: Sorry can't commment much as we have to go floss right now!

Alarming concern: Has Bird flu H5N1virus mutated for human to human tranmission?"

"With no animal identified as yet as the source of infection, this cluster raises the suspicion of human-to-human transmission," Jennifer McKimm-Breschkin, a virologist at Australia's Commonwealth Science and Industrial Research Organization (CSIRO) in Melbourne said. "It warrants further urgent investigation, especially of people who may have come into contact with the infected people." Officials from the WHO and the U.S. Centers for Disease Control and Prevention joined local authorities last week on the Indonesian island of Sumatra to try to pinpoint how the people became infected with H5N1 in the past month

See Full Story from Bloomberg

Stem cells may help incontinence

The researchers described the treatment as a cure, meaning that the patients did not need to wear pads after they were treated. "It's highly effective, and it's much more effective than we previously thought," said lead author Hannes Strasser. "If somebody had told me it would have worked so well four years ago, I would not have believed it.

See full story Wall Street Journal Online

DNA mutations may offer cancer protection

Studies have long shown the more mutations in a cell's DNA, the higher the risk of cancer developing. But in the last few years it has become clear the very processes that generate mutations -- if they take place at a relatively low frequency -- can protect against cancer.

United Press International - NewsTrack - DNA mutations may offer cancer protection

QIAGEN Agrees to Acquire Gentra Systems Inc

BioBOOM Op/Ed: Is this more big fish eating little fish or just a smart use of money? You can spend millions a year fighting them in the market or just buy the buggars. Of course we don't see much staying around in Minnesota now. Gives Qiagen a dominating position in the molecular diagnostic front end. In the other market segments it looks like the battle is joined now with Qiagen and the two other "majors" Invitrogen and Sigma-Aldrich.

One thought = what does Gentra' distributors do? Sure they will want to continue selling DNA and RNA prep and not just let Qiagen get the revenue. Keep an eye on Promega, Epicenter, Tepnel and Zymo Research. Any other wanna be's don't have any differentiation, products for clinical like viral RNA, nor the type of management needed to grow in that market.

QIAGEN Agrees to Acquire Gentra Systems Inc.: Financial News - Yahoo! Finance